ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 183 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 4.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,011,315 | +191.4% | 180,064 | +458.3% | 0.00% | +200.0% |
| Q2 2023 | $690,193 | -60.3% | 32,252 | -25.0% | 0.00% | -66.7% |
| Q1 2023 | $1,738,880 | +89.3% | 42,999 | +117.7% | 0.00% | +50.0% |
| Q4 2022 | $918,723 | -10.3% | 19,749 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,024,000 | +14.7% | 19,749 | +4.6% | 0.00% | +100.0% |
| Q2 2022 | $893,000 | -35.0% | 18,889 | -2.1% | 0.00% | -50.0% |
| Q1 2022 | $1,373,000 | -4.1% | 19,294 | +0.7% | 0.00% | 0.0% |
| Q4 2021 | $1,432,000 | +29.8% | 19,155 | -1.3% | 0.00% | 0.0% |
| Q3 2021 | $1,103,000 | +28.3% | 19,410 | -0.7% | 0.00% | +100.0% |
| Q2 2021 | $860,000 | -15.1% | 19,540 | -4.9% | 0.00% | -50.0% |
| Q1 2021 | $1,013,000 | +15.1% | 20,546 | -1.7% | 0.00% | +100.0% |
| Q4 2020 | $880,000 | -18.4% | 20,909 | -11.2% | 0.00% | -50.0% |
| Q3 2020 | $1,078,000 | +0.7% | 23,549 | +10.5% | 0.00% | 0.0% |
| Q2 2020 | $1,070,000 | -18.6% | 21,302 | -16.7% | 0.00% | -33.3% |
| Q1 2020 | $1,315,000 | -71.9% | 25,566 | -66.2% | 0.00% | -57.1% |
| Q4 2019 | $4,678,000 | +133.5% | 75,707 | +127.1% | 0.01% | +133.3% |
| Q3 2019 | $2,003,000 | -29.5% | 33,330 | -1.0% | 0.00% | -25.0% |
| Q2 2019 | $2,841,000 | -9.9% | 33,664 | +2.0% | 0.00% | -20.0% |
| Q1 2019 | $3,153,000 | +13.5% | 33,014 | -15.8% | 0.01% | 0.0% |
| Q4 2018 | $2,778,000 | -85.2% | 39,229 | -82.2% | 0.01% | -82.1% |
| Q3 2018 | $18,785,000 | -46.4% | 219,815 | -27.4% | 0.03% | -46.2% |
| Q2 2018 | $35,070,000 | +99.6% | 302,587 | +39.3% | 0.05% | +92.6% |
| Q1 2018 | $17,573,000 | +223.0% | 217,190 | +134.2% | 0.03% | +285.7% |
| Q4 2017 | $5,441,000 | +149.5% | 92,732 | +99.0% | 0.01% | +133.3% |
| Q3 2017 | $2,181,000 | +31.5% | 46,597 | +1.1% | 0.00% | +50.0% |
| Q2 2017 | $1,659,000 | -22.7% | 46,107 | -33.8% | 0.00% | -33.3% |
| Q1 2017 | $2,146,000 | +30.9% | 69,671 | +42.4% | 0.00% | 0.0% |
| Q4 2016 | $1,639,000 | -24.3% | 48,928 | -39.9% | 0.00% | -25.0% |
| Q3 2016 | $2,166,000 | +108.7% | 81,404 | +72.9% | 0.00% | +100.0% |
| Q2 2016 | $1,038,000 | -27.5% | 47,074 | -3.4% | 0.00% | -33.3% |
| Q1 2016 | $1,431,000 | +42.7% | 48,714 | +60.4% | 0.00% | +50.0% |
| Q4 2015 | $1,003,000 | -6.8% | 30,370 | +2.0% | 0.00% | 0.0% |
| Q3 2015 | $1,076,000 | -46.8% | 29,770 | -33.8% | 0.00% | -50.0% |
| Q2 2015 | $2,023,000 | +241.7% | 44,970 | +200.4% | 0.00% | +300.0% |
| Q3 2014 | $592,000 | +44.0% | 14,970 | -0.7% | 0.00% | 0.0% |
| Q4 2013 | $411,000 | – | 15,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |